Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CSTL

Castle Biosciences (CSTL)

Castle Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CSTL
DateTimeSourceHeadlineSymbolCompany
28/02/202508:13Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CSTLCastle Biosciences Inc
28/02/202508:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSTLCastle Biosciences Inc
28/02/202508:05Business WireCastle Biosciences Reports Fourth Quarter and Full-Year 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
26/02/202508:30Business WireCastle Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CSTLCastle Biosciences Inc
25/02/202508:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
13/02/202508:30Business WireCastle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology Conference - Hawaii®NASDAQ:CSTLCastle Biosciences Inc
06/02/202523:00Business WireCastle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025NASDAQ:CSTLCastle Biosciences Inc
17/01/202523:00Business WireCastle’s Poster on DecisionDx®-SCC Selected as a “Late Breakers” Top Five Finalist for the Akamai Award, Recognizing the Best Posters at Maui Derm Hawaii 2025NASDAQ:CSTLCastle Biosciences Inc
13/01/202510:00Business WireCastle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
09/01/202510:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
07/01/202508:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CSTLCastle Biosciences Inc
06/01/202523:00Business WireCastle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus TestNASDAQ:CSTLCastle Biosciences Inc
23/12/202423:00Business WireCastle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile TestNASDAQ:CSTLCastle Biosciences Inc
19/12/202423:00Business WireCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CSTLCastle Biosciences Inc
12/12/202423:00Business WireIndependent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with MelanomaNASDAQ:CSTLCastle Biosciences Inc
12/12/202408:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
12/12/202408:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
12/12/202408:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
20/11/202423:00Business WireCastle Biosciences to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CSTLCastle Biosciences Inc
20/11/202408:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
19/11/202423:00Business WireCastle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive YearNASDAQ:CSTLCastle Biosciences Inc
15/11/202405:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CSTLCastle Biosciences Inc
08/11/202423:00Business WireCastle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual MeetingNASDAQ:CSTLCastle Biosciences Inc
08/11/202408:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
07/11/202423:00Business WireCastle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher® Barrett’s Esophagus TestNASDAQ:CSTLCastle Biosciences Inc
06/11/202423:00Business WireUse of Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures, Latest Findings from Prospective, Multicenter DECIDE Study Presented at Dermato-Onco2024NASDAQ:CSTLCastle Biosciences Inc
06/11/202408:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
05/11/202408:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSTLCastle Biosciences Inc
05/11/202408:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSTLCastle Biosciences Inc
05/11/202408:05Business WireCastle Biosciences Reports Third Quarter 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CSTL